Cargando…
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy
BACKGROUND/AIMS: For metastatic renal cell carcinoma (RCC), various prognostic scoring systems have been developed. However, owing to the low prevalence of nonclear cell RCC, the three most commonly used tools were mainly developed based on patients with clear cell histology. Accordingly, this study...
Autores principales: | Lee, In Hee, Kang, Byung Woog, Kim, Jong Gwang, Bae, Woo Kyun, Ki, Myung Seo, Park, Inkeun, Jo, Jae-Cheol, Kim, Jin Young, Koh, Sung Ae, Lee, Kyung Hee, Cho, Yoon Young, Ryoo, Hun Mo, Kwak, Sang Gyu, Lee, Jung Lim, Lee, Sun Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960037/ https://www.ncbi.nlm.nih.gov/pubmed/30301310 http://dx.doi.org/10.3904/kjim.2018.064 |
Ejemplares similares
-
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019) -
Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures
por: Park, Inkeun, et al.
Publicado: (2019) -
Metastatic clear cell renal carcinoma – an unusual response
to Temsirolimus in second line therapy
por: Stanculeanu, DL, et al.
Publicado: (2016) -
Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
por: Boni, J P, et al.
Publicado: (2008) -
A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma
por: Cho, Kang Su, et al.
Publicado: (2008)